Status:
RECRUITING
The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment
Lead Sponsor:
Tanta University
Conditions:
COVID
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
Efficacy of Ivermectin in larger doses in COVID-19 treatment
Detailed Description
Clinical Study Evaluating the Efficacy of Ivermectin in higher doses in COVID-19 treatment
Eligibility Criteria
Inclusion
- Patients with covid 19
Exclusion
- Allergy or side effects to treatment
Key Trial Info
Start Date :
June 16 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04351347
Start Date
June 16 2020
End Date
December 1 2030
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, Egypt, 35111